People’s Pharmacy: Can long-term use of losartan lead to hand tremors?

If you and your doctor will be considering a different antihypertensive drug, you may want to read the "eGuide to Blood ...

NHS losartan warning to 'call 999' if you have 8 symptoms

In rare instances, it's possible to have a serious allergic reaction (anaphylaxis) to losartan. In such cases, you should ...
Seeking Alpha

SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli ™ as the first FDA-approved ready-to-use oral suspension “This represents a paradigm ...
WJHL-TV

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...

NHS losartan warning as common drug may be 'unsuitable' for some people

The NHS has warned that a “widely used” drugs may not be suitable for certain people. Losartan, which is often prescribed to ...
Investing

Scienture and BlinkRx partner to expand access to liquid losartan

COMMACK, NY - Scienture Holdings, Inc. (NASDAQ:SCNX) and BlinkRx LLC announced Wednesday a strategic collaboration to expand access to Arbli, the first FDA-approved ready-to-use oral suspension ...
Business Insider

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned ...